Skip to content
DeepViews

Cognex Corp (CGNX) — Analysis Summary

Cognex Corp (CGNX) has a market cap of $10.40B with year-over-year revenue growth of +8.7%. Net margin stands at 11.5%. The stock trades at a P/E ratio of 59.5.

Key Takeaways

  • Revenue changed +8.7% year-over-year
  • Net margin of 11.5%
  • P/E ratio of 59.5

Compared to other companies in the INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL sector, CGNX posted revenue growth of +8.7% and trades at a P/E of 59.5.

[XNAS]

Cognex Corp (CGNX)

$61.82

PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$10.40B
Enterprise Value
$9995.23M
P/E Ratio
59.5
Div Yield
0.55%
EV/EBITDA
38.8
Company Profile
About
About Cognex Corp

Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. Geographically, it operates in United states, Europe, Greater China and others. Cognex generates the maximum proportion of its sales in the United States and Europe.

Sector

INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL

Employees

2,745

Headquarters

NATICK, MA

Exchange

XNAS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
52
Narrow Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$1629.56M
Total Debt$0.00M
Debt-to-Equity0.00
Cash & Equivalents$302.52M

Cash Flow

Operating Cash Flow$276.63M
Free Cash Flow$268.30M
FCF Margin24.64%
P/FCF Ratio38.76
Source: Polygon.io · SEC EDGAR
Dividends
Dividends

Annual Dividend/Share

$0.34

Dividend Yield

0.55%

Quarterly
Last Ex-Date: 2026-08-20

Dividend History

2026-08-20
CD$0.0850
2026-05-21
CD$0.0850
2026-02-26
CD$0.0850
2025-11-13
CD$0.0850
Source: Polygon.io
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.